analyst
OS
NYSE · OSCR
Oscar Health, Inc.
Healthcare · Medical - Healthcare Plans
$32.44
Down-$0.41 (-1.26%)
Updated Sep 16, 2026, 3:10 PM
SID Score
6.4/10
Composite research score
Smart Money
62/100
Neutral
- Market cap
- 4.05B
- P/E ratio
- -16.61
- Dividend yield
- 0.00%
- 52-week range
- $10.69 – $34.48
- Volume
- 4.27M
- Avg. volume
- 16.31M
Price performance
OSCR price history
1M range · 20 trading sessions · Daily adjusted prices
OSCR closed at $32.44 after 20 trading sessions, up 3.71% for the selected period.
- Last close
- $32.44
- Period change
- +3.71%
- Period low
- $29.83
- Period high
- $33.81
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $33.50 | $33.72 | $32.30 | $32.44 | 4.27M |
| Sep 14, 2026 | $33.02 | $34.48 | $32.83 | $33.81 | 5.14M |
| Sep 11, 2026 | $33.04 | $34.23 | $32.58 | $32.77 | 7.1M |
| Sep 10, 2026 | $31.75 | $33.4699 | $31.38 | $32.58 | 4.11M |
| Sep 9, 2026 | $33.15 | $33.20 | $30.44 | $31.76 | 5.21M |
| Sep 8, 2026 | $32.00 | $33.24 | $31.46 | $33.01 | 4.76M |
| Sep 4, 2026 | $32.19 | $32.485 | $31.53 | $32.25 | 3.69M |
| Sep 3, 2026 | $30.65 | $32.33 | $30.46 | $32.24 | 4.8M |
| Sep 2, 2026 | $30.00 | $30.74 | $29.375 | $30.33 | 4.58M |
| Sep 1, 2026 | $29.81 | $30.50 | $29.085 | $29.83 | 5.01M |
| Aug 31, 2026 | $30.30 | $30.469 | $29.57 | $29.96 | 3.65M |
| Aug 28, 2026 | $30.00 | $31.51 | $29.24 | $30.47 | 5.18M |
| Aug 27, 2026 | $31.18 | $31.28 | $29.96 | $30.05 | 5.18M |
| Aug 26, 2026 | $30.59 | $32.59 | $30.302 | $31.24 | 3.4M |
| Aug 25, 2026 | $32.29 | $32.31 | $30.37 | $30.93 | 3.38M |
| Aug 24, 2026 | $32.17 | $33.548 | $31.41 | $31.81 | 4.68M |
| Aug 21, 2026 | $31.43 | $32.06 | $30.60 | $32.04 | 5.36M |
| Aug 20, 2026 | $32.16 | $33.48 | $31.27 | $31.57 | 6.87M |
| Aug 19, 2026 | $30.87 | $32.44 | $30.50 | $32.30 | 3.87M |
| Aug 18, 2026 | $31.27 | $32.2763 | $31.18 | $31.28 | 4.3M |
Latest OSCR news
The latest Smart Investors Daily articles mentioning OSCR.
Stock researchResearch & News · Competitors
Loading stock research…